Boost for analysts

The ASX has extended its trial equity research subsidy program for another year after 60per cent of the companies covered reported an increase in turnover of their securities in the past year. The scheme was introduced to help smaller companies get analyst coverage, and for larger research houses to cover companies that they would otherwise ignore.